Glucagon-like peptide-1 (GLP-1) receptor agonists have become one of the most prescribed drug classes in metabolic medicine - and for good reason. Their efficacy data in weight loss and glycemic control is among the strongest we have seen. But clinical mastery requires more than knowing the dose...